3 Cardiac arrhythmias affected 2-11% of participants on retatrutide versus 2% on placebo, but none were serious
Sustainable weight loss preserves muscle mass, protects metabolic function, and reduces the likelihood of weight regain
Sales: $27.1 Billion Headcount: 18,000 Revenues: $27,116 (flat) Net Income: $5,613 (+23%) R&D Expenses: $5,718 (+15%) Gileads full year 2023 revenue decreased 1% to $27.1 billion compared to 2022, largely driven by a reduction of $1.7 billion in Veklury sales, but offset by higher HIV and Oncology sales
A recent genome-wide association study also identified the gene NBEA (neurobeachin) as likely contributing to differences in weight loss on GLP-1s
(BPC-157 and ligament healing in the rat animal-model evidence.) Reviewed by Dr